Patent details
EP3423061 Title: COMBINATION THERAPY WITH SORAFENIB OR REGORAFENIB AND A PHOSPHORAMIDATE PRODRUG OF TROXACITABINE
Basic Information
- Publication number:
- EP3423061
- PCT Application Number:
- SE2017050186
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP177604006
- PCT Publication Number:
- WO2017151044
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION THERAPY WITH SORAFENIB OR REGORAFENIB AND A PHOSPHORAMIDATE PRODRUG OF TROXACITABINE
- French Title of Invention:
- TRAITEMENT D'ASSOCIATION UTILISANT DU SORAFÉNIB OU DU RÉGORAFÉNIB ET UN PROMÉDICAMENT DE LA TROXACITABINE DE TYPE PHOSPHORAMIDATE
- German Title of Invention:
- KOMBINATIONSTHERAPIE MIT SORAFENIB ODER REGORAFENIB UND PHOSPHORAMIDAT-PRODRUG VON TROXACITABIN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 21/08/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/09/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/08/2024
- Unitary Effect Registration Date:
- 02/09/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 28/02/2017
- Grant date:
- 07/08/2024
- EP Publication Date:
- 09/01/2019
- PCT Publication Date:
- 08/09/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/08/2024
- EP B1 Publication Date:
- 07/08/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 28/02/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/07/2024
- Name:
- Medivir Aktiebolag
- Address:
- P.O. Box 1086, 141 22 Huddinge, Sweden (SE)
Inventor
1
- Name:
- KLASSON, Björn
- Address:
- Sweden (SE)
2
- Name:
- ENEROTH, Anders
- Address:
- Sweden (SE)
3
- Name:
- ÖHD, John
- Address:
- Sweden (SE)
4
- Name:
- ALBERTELLA, Mark
- Address:
- Sweden (SE)
5
- Name:
- ÖBERG, Fredrik
- Address:
- Sweden (SE)
Priority
1
- Priority Number:
- 1650274
- Priority Date:
- 02/03/2016
- Priority Country:
- Sweden (SE)
2
- Priority Number:
- 1651204
- Priority Date:
- 08/09/2016
- Priority Country:
- Sweden (SE)
Classification
- IPC classification:
- A61K 31/513; A61K 31/4412; A61K 31/675; A61K 31/685; A61P 35/00; A61K 31/44;
Publication
European Patent Bulletin
1
- Issue number:
- 202432
- Publication date:
- 07/08/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202439
- Publication date:
- 25/09/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202440
- Publication date:
- 02/10/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|